A Randomized Phase III Study Evaluating the Continuation of Bevacizumab (BV) Beyond Progression in Metastatic Colorectal Cancer (MCRC) Patients (PTS) Who Received BV as Part of First-Line Treatment: Results of the Bebyp Trial by the Gruppo Oncologico Nord Ovest (GONO)
Masi, G., Loupakis, F., Salvatore, L., Cremolini, C., Fornaro, L., Schirripa, M., Fea, E., Granetto, C., Antonuzzo, L., Giommoni, E., Allegrini, G., Cupini, S., Boni, C., Banzi, M., Chiara, S., SonaglVolume:
23
Journal:
Annals of Oncology
DOI:
10.1016/s0923-7534(20)34318-0
Date:
September, 2012
File:
PDF, 62 KB
2012